Skip to content
Open access · CC-BY via OpenAlex

Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients

Enrico Derenzini, Angela Gueli, Alessandra Risso, Riccardo Bruna, Daniela Gottardi, Alessandro Cignetti, Stefano Aldo Pileri, Enrico Vittorio Avvedimento, Corrado Tarella

Hematological Oncology · 2022

Abstract

Although chemotherapy (CHT) exposure is an established cause of telomere(definition) attrition, determinants of telomere length (TL) dynamics after chemotherapy are poorly defined. In this study, we analyzed granulocyte telomere dynamics in 34 adult lymphoma patients undergoing first-line CHT. TL was measured by southern blot at each CHT cycle and after 1 year from CHT completion. Median age was 59 yrs (range 22-77). Median number of CHT cycles was 6 (range 3-6). The majority of patients (79%, n = 27) experienced TL shortening following CHT exposure. Mean telomere loss was 673 base pairs (bp) by cycle 6. Telomere shortening was an early event as 87% of the total telomere loss (mean 586 bp) occurred by the end of cycle 3, with no significant recovery after 1 year. A significant correlation was observed between baseline TL and total or fractional telomere loss (p < 0.001), with telomere shortening by cycle 3 observed predominantly in male patients with long telomeres at pre-treatment evaluation. Stratifying the analysis by gender and age only young women (<51 years of age) did not show significant telomere shortening following chemotherapy exposure. These findings indicate that gender and baseline TL are major determinants of TL dynamics following chemotherapy exposure in lymphoma patients.

◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:

Read at source →

Provenance

Source
OpenAlex
DOI
10.1002/hon.3118
Canonical
link ↗
Fetched
2026-10-04 MST

Cite this

APA
Derenzini, E., Gueli, A., Risso, A., Bruna, R., Gottardi, D., Cignetti, A., Pileri, S.A., Avvedimento, E.V., &amp; Tarella, C. (2022). Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients. <em>Hematological Oncology</em>. https://doi.org/10.1002/hon.3118
Vancouver
Derenzini E, Gueli A, Risso A, Bruna R, Gottardi D, Cignetti A, et al. Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients. Hematological Oncology. 2022. doi:10.1002/hon.3118.
BibTeX
@article{enrico2022Longte, title = {Long telomeres at baseline and male sex are main determinants of telomere loss following chemotherapy exposure in lymphoma patients}, author = {Enrico Derenzini and Angela Gueli and Alessandra Risso and Riccardo Bruna and Daniela Gottardi and Alessandro Cignetti and Stefano Aldo Pileri and Enrico Vittorio Avvedimento and Corrado Tarella}, journal = {Hematological Oncology}, year = {2022}, doi = {10.1002/hon.3118}, }

Research neighborhood

References, citing works, and semantically nearest findings. Click a node to open it.

Related findings